Back to Startups

AusperBio

Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Website
About AusperBio

A clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies.

Business Information
Target Customers
pharmaceutical companies research institutions healthcare providers
Industry Categories
Bioscience & Disease Healthcare Systems
Business Model
Revenue Model B2B partnerships and licensing
Pricing Strategy Negotiated contracts based on project scope
Sales Channels direct sales, partnerships with pharmaceutical companies
Funding Timeline
Round Date Amount Investors
Series B May 29, 2025 $50.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
raisingfi
Raising.fi @raisingfi
May 29, 2025

New Raise 🏛️ Company: AusperBio 🔗 Website: https://t.co/okGtQ9eCwc 📊 Amount: $50 Million 🔄 Round: Series B+ 🧮 Valuation: N/A ⚙️ Industry: Biotechnology

View on Twitter
finSMEs
FinSMEs @finSMEs
May 29, 2025

AusperBio, a San Francisco, CA- and Hangzhou, China-based clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, raised $50M in Series B+ funding https://t.co/bM53foWP8h

View on Twitter
Similar Startups
Fore Biotherapeutics
88% match

Fore Biotherapeutics is a biotechnology company focused on developing innovative therapies for patie...
CureGene Pharma
87% match

CureGene focuses on therapeutic areas including cardiovascular and metabolic diseases, developing in...
Alpheus Medical
87% match

A private, clinical-stage oncology company focused on developing innovative therapies for cancer tre...
biostateai
86% match

BiostateAI is an innovative company leveraging artificial intelligence and RNA sequencing technologi...